These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 29611179)

  • 1. Anti-α
    Fiore M; d'Oiron R; Pillois X; Alessi MC
    Br J Haematol; 2018 Apr; 181(2):173-182. PubMed ID: 29611179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First description of an IgM monoclonal antibody causing α
    Pillois X; Guy A; Choquet É; James C; Tuffigo M; Viallard JF; Garcia C; Bordet JC; Jandrot-Perrus M; Payrastre B; Fiore M
    J Thromb Haemost; 2019 May; 17(5):795-802. PubMed ID: 30868743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunization against α
    Fiore M; Bayat B; Phuangtham R; Blouin L; Huguenin Y; Bein G; Santoso S
    J Thromb Haemost; 2021 Jan; 19(1):255-261. PubMed ID: 33090654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glanzmann's thrombasthenia treatment: a prospective observational registry on the use of recombinant human activated factor VII and other hemostatic agents.
    Poon MC; Zotz R; Di Minno G; Abrams ZS; Knudsen JB; Laurian Y
    Semin Hematol; 2006 Jan; 43(1 Suppl 1):S33-6. PubMed ID: 16427383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of allo-immunization anti-HLA and anti-integrin alphaIIbbeta3 in Glanzmann Thromboasthenia patients.
    Santoro C; Rago A; Biondo F; Conti L; Pulcinelli F; Laurenti L; Perrone MP; Baldacci E; Leporace A; Mazzucconi MG
    Haemophilia; 2010 Sep; 16(5):805-12. PubMed ID: 20345392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New Insights Into the Treatment of Glanzmann Thrombasthenia.
    Poon MC; Di Minno G; d'Oiron R; Zotz R
    Transfus Med Rev; 2016 Apr; 30(2):92-9. PubMed ID: 26968829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A unique phenotype of acquired Glanzmann thrombasthenia due to non-function-blocking anti-αIIbβ3 autoantibodies.
    Akuta K; Kashiwagi H; Yujiri T; Nishiura N; Morikawa Y; Kato H; Honda S; Kanakura Y; Tomiyama Y
    J Thromb Haemost; 2019 Jan; 17(1):206-219. PubMed ID: 30388316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AlphaIIbG236E causes Glanzmann thrombasthenia by impairing association with beta3.
    Afrasiabi A; Gelain F; Artoni A; Mannucci PM
    Platelets; 2008 Aug; 19(5):322-7. PubMed ID: 18791937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel Pro126His beta propeller mutation in integrin alphaIIb causes Glanzmann thrombasthenia by impairing progression of pro-alphaIIbbeta3 from endoplasmic reticulum to Golgi.
    Shen WZ; Ding QL; Jin PP; Wang XF; Jiang YZ; Li SM; Wang HL
    Blood Cells Mol Dis; 2009; 42(1):44-50. PubMed ID: 18976939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunisation against αIIbβ3 and αvβ3 in a type 1 variant of Glanzmann's thrombasthenia caused by a missense mutation Gly540Asp on β3.
    Wihadmadyatami H; Röder L; Berghöfer H; Bein G; Heidinger K; Sachs UJ; Santoso S
    Thromb Haemost; 2016 Aug; 116(2):262-71. PubMed ID: 27098940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sustained engraftment post bone marrow transplant despite anti-platelet antibodies in Glanzmann thrombasthenia.
    Flood VH; Johnson FL; Boshkov LK; Thomas GA; Nugent DJ; Bakke AC; Nicholson HS; Tilford D; Brown MP; Godder KT
    Pediatr Blood Cancer; 2005 Dec; 45(7):971-5. PubMed ID: 15768382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular analysis of a patient with type I Glanzmann thrombasthenia and clinical impact of the presence of anti-αIIbβ3 alloantibodies.
    Kashiwagi H; Kiyomizu K; Kamae T; Nakazawa T; Tadokoro S; Takiguchi S; Doki Y; Kanakura Y; Tomiyama Y
    Int J Hematol; 2011 Jan; 93(1):106-11. PubMed ID: 21136216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful management of perioperative hemostasis in a patient with Glanzmann thrombasthenia who underwent a right total mastectomy.
    Ogawa Y; Kunishima S; Yanagisawa K; Osaki Y; Uchiyama Y; Matsumoto N; Tokiniwa H; Horiguchi J; Nojima Y; Handa H
    Int J Hematol; 2017 Feb; 105(2):221-225. PubMed ID: 27696190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glanzmann's thrombasthenia (defective platelet integrin alphaIIb-beta3): proposals for management between evidence and open issues.
    Di Minno G; Coppola A; Di Minno MN; Poon MC
    Thromb Haemost; 2009 Dec; 102(6):1157-64. PubMed ID: 19967146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic expression of the platelet-specific integrin, alphaIIbbeta3, in a murine model for Glanzmann thrombasthenia.
    Fang J; Hodivala-Dilke K; Johnson BD; Du LM; Hynes RO; White GC; Wilcox DA
    Blood; 2005 Oct; 106(8):2671-9. PubMed ID: 15972454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel 196Leu to Pro substitution in the beta3 subunit of the alphaIIbbeta3 integrin in a patient with a variant form of Glanzmann thrombasthenia.
    Nurden AT; Ruan J; Pasquet JM; Gauthier B; Combrié R; Kunicki T; Nurden P
    Platelets; 2002 Mar; 13(2):101-11. PubMed ID: 11897046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein A Sepharose immunoadsorption can restore the efficacy of platelet concentrates in patients with Glanzmann's thrombasthenia and anti-glycoprotein IIb-IIIa antibodies.
    Martin I; Kriaa F; Proulle V; Guillet B; Kaplan C; D'Oiron R; Debré M; Fressinaud E; Laurian Y; Tchernia G; Charpentier B; Lambert T; Dreyfus M
    Br J Haematol; 2002 Dec; 119(4):991-7. PubMed ID: 12472579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A two-amino acid insertion in the Cys146- Cys167 loop of the alphaIIb subunit is associated with a variant of Glanzmann thrombasthenia. Critical role of Asp163 in ligand binding.
    Honda S; Tomiyama Y; Shiraga M; Tadokoro S; Takamatsu J; Saito H; Kurata Y; Matsuzawa Y
    J Clin Invest; 1998 Sep; 102(6):1183-92. PubMed ID: 9739052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural history of platelet antibody formation against αIIbβ3 in a French cohort of Glanzmann thrombasthenia patients.
    Fiore M; Firah N; Pillois X; Nurden P; Heilig R; Nurden AT
    Haemophilia; 2012 May; 18(3):e201-9. PubMed ID: 22250950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diversity of Glanzmann thrombasthenia in southern India: 10 novel mutations identified among 15 unrelated patients.
    Nelson EJ; Nair SC; Peretz H; Coller BS; Seligsohn U; Chandy M; Srivastava A
    J Thromb Haemost; 2006 Aug; 4(8):1730-7. PubMed ID: 16879215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.